Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-064708
Filing Date
2022-05-25
Accepted
2022-05-25 17:18:47
Documents
4
Period of Report
2022-07-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2216871-1_def14a.htm DEF 14A 866654
2 GRAPHIC lg_onconova-4c.jpg GRAPHIC 51794
3 GRAPHIC tm2216871d1-px_01onconovabw.jpg GRAPHIC 538249
4 GRAPHIC tm2216871d1-px_02onconovabw.jpg GRAPHIC 423493
  Complete submission text file 0001104659-22-064708.txt   2263914
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36020 | Film No.: 22964177
SIC: 2834 Pharmaceutical Preparations